NNovo Nordisk Read More After A Rough Week, HIMS May Have Found Its Catalyst – JPMorgan Sees ‘Compelling Path2026-04-24 JPMorgan initiated coverage of Hims & Hers with an ‘Overweight’ rating and a price target of $35, according…
